Post-Activity Test and Activity Evaluation

POST TEST

Question Title

1. Compared to those without insomnia, those with insomnia have a higher risk of: (Required.)

Diabetes

Hypertension

Depression

All of the above

Question Title

2. Risk factors for insomnia include all of the following except: (Required.)

Older age

Cigarette smoking

Regular exercise

Alcohol or caffeine consumption

Question Title

3. When should the primary care provider ask a patient about sleep problems? (Required.)

During a routine health assessment visit

During an acute care visit

During follow-up visits

All of the above

Question Title

4. First-line management approach for the treatment of insomnia is: (Required.)

Sleep hygiene and cognitive behavioral therapy

Benzodiazepine-receptor agonist

Sedating antidepressant

Melatonin supplement

Question Title

5. Orexin-receptor antagonists (e.g., suvorexant) can be considered for use in patients that have issues with: (Required.)

Sleep onset only

Sleep maintenance only

Sleep onset or sleep maintenance

Neither sleep onset nor sleep maintenance

Question Title

6. In the SUNRISE-1 clinical trial that compared lemborexant with zolpidem ER and placebo for insomnia, which of the following is true? (Required.)

Lemborexant significantly improved sleep onset only when compared to zolpidem ER and placebo

Lemborexant significantly improved sleep maintenance only when compared to zolpidem ER and placebo

Lemborexant significantly improved sleep onset and sleep maintenance when compared to zolpidem ER and placebo

There was no difference in sleep onset or sleep maintenance with lemborexant compared to zolpidem ER or placebo

Question Title

* 1. Compared to those without insomnia, those with insomnia have a higher risk of: (Required.)

Question Title

* 2. Risk factors for insomnia include all of the following except: (Required.)

Question Title

* 3. When should the primary care provider ask a patient about sleep problems? (Required.)

Question Title

* 4. First-line management approach for the treatment of insomnia is: (Required.)

Question Title

* 5. Orexin-receptor antagonists (e.g., suvorexant) can be considered for use in patients that have issues with: (Required.)

Question Title

* 6. In the SUNRISE-1 clinical trial that compared lemborexant with zolpidem ER and placebo for insomnia, which of the following is true? (Required.)

1. Compared to those without insomnia, those with insomnia have a higher risk of: (Required.)

2. Risk factors for insomnia include all of the following except: (Required.)

3. When should the primary care provider ask a patient about sleep problems? (Required.)

4. First-line management approach for the treatment of insomnia is: (Required.)

5. Orexin-receptor antagonists (e.g., suvorexant) can be considered for use in patients that have issues with: (Required.)

6. In the SUNRISE-1 clinical trial that compared lemborexant with zolpidem ER and placebo for insomnia, which of the following is true? (Required.)